Get 40% Off
Is NVDA a 🟢 buy or 🔴 sell?Unlock Now

Ensysce Biosciences Inc (ENSC)

NASDAQ
Currency in USD
Disclaimer
0.89
0.00(-0.56%)
Closed
After Hours
0.90+0.01(+1.12%)
Day's Range
0.840.92
52 wk Range
0.768.90
Prev. Close
0.89
Open
0.88
Day's Range
0.84-0.92
52 wk Range
0.76-8.9
Volume
145,965
Average Vol. (3m)
1,571,589
1-Year Change
-86.14%
Shares Outstanding
6,747,828
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
11.65
Upside +1,208.99%

People Also Watch

3.780
EVAX
-1.31%
3.69
OMGA
+2.93%
2.90
RVSN
-14.71%
8.99
CCCC
+2.16%
0.8975
ACON
-26.43%
How do you feel today about ENSC?
Vote to see community's results!
or

Ensysce Biosciences Inc Company Profile

Ensysce Biosciences, Inc. is a clinical-stage biotech company. The Company is engaged in developing solutions for severe pain relief while reducing the potential for opioid misuse, abuse, and overdose. The Company is using its proprietary technology platforms to develop safer prescription drugs. The Company's development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology - the Trypsin Activated Abuse Protection, (the TAAP platform), and an over-dose protection opioid prodrug technology - the Multi-Pill Abuse Resistant, (MPAR platform). The TAAP platform is designed to improve the care of patients with chronic pain while reducing the human and economic costs associated with prescription opioid drug abuse. The MPAR platform when combined with the Company’s TAAP prodrugs is designed not only to seek to prevent abuse of prescription drugs but also to reduce overdose occurrences.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.